08/04/2025 08:53
EQS-Adhoc: Aumann increases price of share buyback offer to €14.25 per share
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd pEQSAdhoc: Aumann AG / Key words: Share Buybackbr/ Aumann increases price of share buyback offer to €14.25 per share br/br/ 08Apr2025 / 08:53 CET/CESTbr/ Disclosure of an inside information acc. to Article 17... Lire...
08/04/2025 08:30
LIGHTON : LIGHTON appoints Cécile Givron as Chief Financial and Administrative Officer.
html xmlns=http://www.w3.org/1999/xhtmlbody table border= cellpadding= cellspacing=trtd pLIGHTONbr/ LIGHTON appoints Cécile Givron as Chief Financial and Administrative Officer. br/br/span08Apr2025 / 08:30 CET/CEST/spanbr/ Dissemination of a French Regulatory News,... Lire...
08/04/2025 08:00
Molten Ventures Plc : Transaction in Own Shares
html xmlns=http://www.w3.org/1999/xhtmlbody table border= cellpadding= cellspacing=trtd p Molten Ventures Plc GROW; GRW br/ Transaction in Own Shares br/br/span08Apr2025 / 07:00 GMT/BST/spanbr/br//p hr/divdiv p style=margintop:0pt;... Lire...
08/04/2025 08:00
Quantum Genomics : Quantum Genomics provides an update on its situation
p align=centerstrongQuantum Genomics provides an update on its situation/strong/p ul listrongTrading suspension of the shares of the Company decided by Euronext since October 25supth/sup, 2024/strong/li listrongSearch for a suitable reverse take over partner initiated in December 2024 and still... Lire...
08/04/2025 08:00
Ondine Biomedical Inc : Ondine Biomedical Inc. Announces Steriwave in First Swiss Hospital
pistrongSwitzerlands University Hospital Zurich undertakes independent research study on Steriwave for preoperative nasal decolonization/strong/i/p pstrong id=datelineVANCOUVER, BC / a href=https://www.accessnewswire.com/ACCESS Newswire/a / April 8, 2025 / /strongOndine Biomedical Inc. LON: OBI... Lire...
08/04/2025 08:00
Pulsar Helium Inc. : Pulsar Helium Announces Execution of US$4 Million Project Finance Facility Line of Credit Note
pistrongTHIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR TO BE TRANSMITTED, DISTRIBUTED TO, OR SENT BY, ANY... Lire...
08/04/2025 07:43
GENSIGHT BIOLOGICS S.A. : INSIDE INFORMATION / OTHER NEWS RELEASES
Press Release GenSight Biologics Announces the Filing of its 2024 Universal Registration Document Paris, France, April 8, 2024, 7:00 am CEST – GenSight Biologics Euronext: SIGHT, ISIN: FR0013183985, PEAPME eligible, a biopharma company focused on developing and... Lire...